Regadenoson

Generic name: Regadenoson
Brand names: Lexiscan
Dosage form: intravenous solution (0.4 mg/5 mL)
Drug class: Cardiac stressing agents

Usage of Regadenoson

Regadenoson is given in preparation for a radiologic (x-ray) examination of blood flow through the heart to test for coronary artery disease.

Regadenoson may also be used for purposes not listed in this medication guide.

Regadenoson side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Tell your caregiver right away if you have:

severe dizziness, fast heartbeats, and warmth or a tingly feeling;

wheezing, chest tightness, trouble breathing;

weak or shallow breathing;

chest pain or pressure, pain spreading to your jaw or shoulder;

a seizure;

low blood pressure--a light-headed feeling, like you might pass out;

high blood pressure--a severe headache or pounding in your neck or ears;

signs of a stroke--sudden numbness or weakness (especially on one side of the body), severe headache, slurred speech, balance problems.

Common side effects of regadenoson may include:

trouble breathing;

headache, dizziness;

chest pain or discomfort;

nausea; or

flushing (warmth, redness, or tingly feeling).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1 800 FDA 1088.

Before taking Regadenoson

You should not be treated with regadenoson if you are allergic to it, or if you have a serious heart condition such as:

2nd or 3rd degree AV block; or

"sick sinus syndrome" (unless you have a pacemaker).

Receiving regadenoson may increase your risk of having abnormal heartbeats, breathing problems, heart attack, stroke, or cardiac arrest. Talk to your doctor about your specific risk.

Tell your doctor if you have recently been sick with vomiting or diarrhea, or if you have ever had:

asthma or COPD (chronic obstructive pulmonary disease);

chest pain or heart problems;

blood circulation problems;

coronary artery disease (clogged arteries);

seizures;

heart disease or high blood pressure; o

if you also take dipyridamole or theophylline.

It is not known whether regadenoson will harm an unborn baby. Tell your doctor if you are pregnant.

Do not breast-feed within 10 hours after receiving regadenoson. If you use a breast pump during this time, throw out any milk you collect. Do not feed it to your baby.

Relate drugs

How to use Regadenoson

Usual Adult Dose for Radionuclide Myocardial Perfusion Study:

0.4 mg rapid IV injection (approximately 10 seconds) into a peripheral vein using a 22 gauge or larger catheter or needle.Comments: Administer a 5 mL saline flush immediately after injection of this drug. Administer the radionuclide myocardial perfusion imaging agent 10 to 20 seconds after the saline flush. The radionuclide may be injected directly into the same catheter as this drug.Use: Radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.

Warnings

You should not receive regadenoson if you have a serious heart condition such as AV block or "sick sinus syndrome" (unless you have a pacemaker).

What other drugs will affect Regadenoson

Some medicines should not be used within 12 hours before you are treated with regadenoson. Tell your doctor about all other medicines you use, especially:

aminophylline;

dipyridamole; or

theophylline.

Other drugs may affect regadenoson, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.